5-[4-[2-(5-Ethyl-2-Pyridyl)Ethoxy]phenyl] methylene-2-4thiazolidinedione
![5-[4-[2-(5-Ethyl-2-Pyridyl)Ethoxy]phenyl] methylene-2-4thiazolidinedione](/img/v2021/product_image.png)
Product Description
J P N PHARMA PRIVATE LIMITED
-
IN -
2015On CPHI since
Specifications
J P N PHARMA PRIVATE LIMITED
-
IN
-
2015On CPHI since
More Products from J P N PHARMA PRIVATE LIMITED (47)
-
Product Alendronate Sodium
Osteoporosis Bulk Drug -
Product Glycopyrrolate
Active Pharmaceutical Ingredient -
Product Alendronic Acid
Intermediate of Alendronate Sodium -
Product 4 Aminobutyric Acid
Intermediate of Alendronate Sodium -
Product Eosin Disodium
Antiseptic Bulk Drug -
Product Pioglitazone HCL
Antidiabetic Bulk Drug -
Product 2-Chloro1,3-BIS(Dimethylamino)Trimethinium Hexa Fluoro Phosphate
Intermediate of Etoricoxib -
Product Tizanidine HCL
Muscle Relaxant Bulk Drug -
Product 5 Chloro 4 Amino 2, 1, 3, benzothiadiazole
Intermediate of Tizanidine HCL -
Product Acetyl Ethylene Urea
Intermediate of Tizanidine HCL -
Product Phenytoin Base / Sodium
Antieplileptic Bulk Drug -
Product Picosulfate Sodium
Laxative Bulk Drug
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance